Last news
OPEN Health Presents First Collection of Research Backed by Scientific Buyout Fund to Foster Research and Development

OPEN Health Presents First Collection of Research Backed by Scientific Buyout Fund to Foster Research and Development

...

EBC Financial Group Registers Trademark in Chile, Strengthening Its Latin American Footprint

EBC Financial Group Registers Trademark in Chile, Strengthening Its Latin American Footprint

...

Monsha’at: Biban24 fuels regional SME growth and development with landmark agreements worth over SAR 35 billion launched during exhibition

Monsha’at: Biban24 fuels regional SME growth and development with landmark agreements worth over SAR 35 billion launched during exhibition

...

Monsha’at: Biban 2024 accelerates transformation of Saudi entrepreneurship with over SAR 10.6 billion worth of agreements

Monsha’at: Biban 2024 accelerates transformation of Saudi entrepreneurship with over SAR 10.6 billion worth of agreements

...

Teva to Present at the Jefferies London Healthcare Conference

Teva to Present at the Jefferies London Healthcare Conference

...

Io Therapeutics, Inc., announces presentation of data on its RAR gamma agonist compound IRX5010 demonstrating inhibition of tumor infiltrating myeloid derived suppressor cells, promotion of tumor infiltrating T-cells, and effective tumor growth inhibition

Io Therapeutics, Inc., announces presentation of data on its RAR gamma agonist compound IRX5010 demonstrating inhibition of tumor infiltrating myeloid derived suppressor cells, promotion of tumor infiltrating T-cells, and effective tumor growth inhibition

Notified -...

Io Therapeutics, Inc., announces presentation of data on its RAR gamma agonist compound IRX5010 demonstrating inhibition of tumor infiltrating myeloid derived suppressor cells, promotion of tumor infiltrating T-cells, and effective tumor growth inhibition

Io Therapeutics, Inc., announces presentation of data on its RAR gamma agonist compound IRX5010 demonstrating inhibition of tumor infiltrating myeloid derived suppressor cells, promotion of tumor infiltrating T-cells, and effective tumor growth inhibition

...

Bitget Protection Fund Hits $424 Million Average, a 40% Increase from its Initial Commitment

Bitget Protection Fund Hits $424 Million Average, a 40% Increase from its Initial Commitment

...

1 ... 495 496 497 498 499 500 501 502 503 ... 1159
menu
menu